chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna has an EUA from the FDA for patients aged 18 and older.  This vaccine was used inappropriately to vaccinate a 17 year old staff member at a clinic hosted by Pharmacy.  Patient experienced no adverse effects, but this improper usage of the vaccination requires reporting to VAERS.
Contract COVID-19 during last week of June. Symptoms were a scratchy throat and sinus irritation/runny nose/nasal dripping in throat. Used Fluticasone Propionate once daily for four days, at which point symptoms were gone.
Friday the 7th when I received the shot I was fine, Saturday the 8th I had a fever and body aches, Sunday the 9th I felt better but my armpit was hurting a lot and was swollen, Monday the 10th my armpit was hurting and swollen and I started to notice a spot on my neck by my jaw line on my left side, tuesday the 11th my armpit started feeling better but the spot on my neck got bigger and I started putting cortisone cream on it, Wednesday the 12th my armpit was feeling much better but the spot on my neck was super itchy and my throat was scratchy so I took Benadryl, today is Thursday the 13th and my armpit is good but my neck is really itchy and hurts to the touch. I?ve been putting cortisone cream on it and still taking Benadryl.
spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed; itchy; swollen; hot to touch; red; Nickel sized, swollen red area; Nickel sized, swollen red area; first 3 days only sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area), VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PAIN IN EXTREMITY (first 3 days only sore arm) and ERYTHEMA (red) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (first 3 days only sore arm). On 07-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area) and ERYTHEMA (red). On 08-Mar-2021, the patient experienced VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PRURITUS (itchy), SWELLING (swollen) and FEELING HOT (hot to touch). At the time of the report, VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area), VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PAIN IN EXTREMITY (first 3 days only sore arm), ERYTHEMA (red), PRURITUS (itchy), SWELLING (swollen) and FEELING HOT (hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Case number PHEH2015US026498, is an initial spontaneous report received from a pharmacist on 16 Dec 2015. This report refers to a female patient of an unknown age. Medical history was not reported. Concomitant medication was not reported. The patient vaccinated with prefilled syringe FLUVIRIN (batch number, expiry date: not reported) on an unknown date; that was out of temperature range at 53 Fahrenheit for 8 hours. No adverse event reported following this administration error (incorrect storage of drug).
Seizure activity noted on 03/22/2023 and 03/24/2023
Dizziness; Palpitation; Shortness of breath; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PALPITATIONS (Palpitation), DYSPNOEA (Shortness of breath) and FATIGUE (Fatigue) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), PALPITATIONS (Palpitation), DYSPNOEA (Shortness of breath) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizziness), PALPITATIONS (Palpitation), DYSPNOEA (Shortness of breath) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Heart rate: 120-130 breaths per minute (Inconclusive) 120-130 beats per minutes. On an unknown date, Heart rate: 170 breaths per minute (High) 170 when climbing steers..         No concomitant medications were provided.  On 05-Mar-2021 and 09-Mar-2021 the patient sought medical attention at the Emergency Room (ER) where she was placed under observation for 7 hours and 4 hours, respectively. On both occasions, the Physician thought her symptoms were due to the vaccine.  No treatment was reported for the events.
Patient marked that she had not had a COVID vaccine dose in the past year on her screening form. Dose was given on 3/11/2021 and Vaccine card was given to patient as her first dose. Upon entering dose, staff noted that a dose was given on 3/06/2021. Vaccine manufacturer was called for recommendations. Moderna was unable to provide any specific recommendations in the event an invalid dose has been administered. The Representative advised to monitor patient and instruct her to present to Urgent Care or Emergency Department if patient experiences any adverse effects.
SWEATING; FEELING OF WARMTH; FEVER; TIREDNESS; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a 19 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced tiredness. On 02-APR-2021, the subject experienced sweating. On 02-APR-2021, the subject experienced feeling of warmth. On 02-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, feeling of warmth, chills, headache, fever, and tiredness on APR-2021. This report was non-serious.
8.15.2021  runny nose, occassional dry cough, and diarrhea.
Side effects; This case was reported by a consumer via interactive digital media and described the occurrence of adverse event in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The patient received Shingrix and experinced adverse event. The patient asked was it ok to take tylenol for adverse event.
Pt recvd Engerix-B on 18JUN92 & 10JUL92 devel rash @ site of inject/itching only 17JUL92 recvd treatment;
This spontaneous report as received from a consumer refers to a 16 year old female patient with learning disabilities with maths and science and Drug allergies/reactions to amoxicillin (manufacturer unknown). Approximately in 2012 (reported as two years ago) the patient was vaccinated with 3 doses of GARDASIL. On 31-JAN-2014 the consumer reported that her daughter had changed. On 31-JAN-2014 the patient started to become dizzy, had convulsions and pseudo seizures. For these adverse reactions the patient had to go two hospital (3 times total) and had to stay there for a couple of days. Approximately in March 2014 (reported as couple weeks ago) the patient experienced mental change. The patient started to become "upset, lashing out at people, repeating herself, having high anxiety, wanting to speak constantly, verbally abusive, having suicidal thoughts, wants to slit her throat and stuck her fingers down her throat to make herself throw up". The patient also started to slur her speech asking her mother if she had a "stroke" and wanted to know if she had "cancer". The patient was admitted to the hospital and then was transferred to another hospital. The reporter stated that the patient was getting beat up by the other patients, but it might be (the patient) provoking them. The outcome was reported as not recovered/not resolved. The reporter believes that GARDASIL had caused the events in her daughter. Additional information has been requested.
11/19/22- woke up with severe dizziness and fatigue- improved slightly over the course of a week, but with progressive weakness (limb) and brain fog/cognitive impairment/vision  problems.  Started Methylprenisolone steroid pack on 11/25 and noted some improvement.  Dizziness continued to rapidly improve but weakness persisted/worsened.  Felt max improvement on day of 12/1, then took a serious turn.  By late evening of 12/1, developed numbness/tingling in both arms.  On 12/2 attempted a short walk and immediately both arms started to tingle and went numb and shortly after the soles of both feet began to tingle.  Attempted to drive later shortly after dark and was unable to focus eyes- called for assistance.  Became progressively weaker and woke on 12/5 pm with difficulty breathing.  Also unable to walk more than a few steps- needed assistance,  Went to ER on 12/6, EKG normal, MRI of brain and spine with and without contrast was normal, sent home in am of 12/7.  Saw PCP on 12/7 and started Prednisone 60 mg daily (1mg/kg).  Noted improvement second day and was able to walk with pole.  Continued to walk with pole for the next week.  Dizziness some better, but still not able to drive, eyes still out of focus.  Have tapered down on steroids, currently on 20 mg on 12/26/22.  Able to drive and walk without assistance, but still with some brain fog and severe fatigue.  Have not been able to work in 6 weeks.  Saw Neuro on 12/20 who stated exam was fine and problems were not neuro related.  Did not perform any evaluation of cognitive function- results were based on touching nose with finger and normal reflexes.
Patient presented to clinic with 3 day history of truncal macular rash. Also had one day history of right lower eyelid lesion.  He had minimal pruritus with the rash, but did have a headache the first two days of the symptoms.  He denied nausea, vomiting, diarrhea, mylagias, or fever at home. Patient had received Vaccinia immunization (left arm) 02MAY2007 along with Anthrax and Typhoid (right arm). This patient was sent to the clinic for further examination of the right eye. He was allowed to go home with precautions regarding transmission of vaccinia. He was seen in the clinic 14MAY07. He will follow-up with our clinic in 3 days.
11/10/22 presents to ED for "fatigue and weakness". PMHx of "Hypertension, Meniere disease, CKD, HLD, Dementia and Anxiety"
Fever x 24 hours, body ache and sore arms x 48 hours. Welts to left arm- (1) anthrax, (1) Tdap >x 5 days.
Patient Syncope / Fainting unknown cause . Onsite EMS was called vitals were taken BP 132/90 HR 88. Patient refused evaluation/care. Left aginst medical advice.
arm tenderness, headache, fatigue, upset stomach, tiggling down arm (all have subsided per patient)
Woke up following morning with extreme body aches, rigors, chills, headache, nasal congestion nausea without vomiting and a fever of 101.3. This persisted for greater than 24 hours and remain the same as of 1/21/2021 at 11:00am
redness to lt leg w/in 15 mins of vax; MD office was called; instructed to apply cool compress & give APAP;
Initial report received from a health care professional on 09 October 2013. This case is the summary of multiple patients. It is reported that several patients of age over 65 had received FLUZONE HD vaccine from September to October (exact date, batch number, route and site of administration not reported). The medical history of the patients is not reported. The concomitant medication details not reported. Reporter states several patients have reported redness, site swelling, site soreness and malaise after FLUZONE HD, stated office has been giving FLUZONE HD since September 2013, patients seen on return visits in October 2013 have reported having these events. Corrective treatment was not provided. It is reported the patients were recovered from the events reported redness, site swelling, site soreness and malaise (stop date not reported). No more information available. Documents held by the sender: none.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 24-NOV-2014, reported as "yesterday", the patient was vaccinated with a dose of ZOSTAVAX 0.65 ml, subcutaneously (lot number and expiration date were not reported) at the reporter's pharmacy. On 25-NOV-2014, reported as "today" the patient went to another unspecified pharmacy and inadvertently received another dose of ZOSTAVAX (dose, route, lot number and expiration date were not reported). No adverse effects were reported. Additional information has been requested.
arm pain, body aches and chills, headache. lasting at this time for over 10 hours
feeling "not quite right"; nausea; headache; arm was sore/ it felt like someone shot him in the arm; This is a spontaneous report from a contactable consumer. A 46-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL0140), via an unspecified route of administration on 24Dec2020 10:00 at SINGLE DOSE at left arm for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. On 31Dec2020, the patient experienced headache, "lungs felt uber clean and clear," and nausea. The patient stated about a week afterward he started feeling "not quite right" He stated his arm was sore for about 12 hours after the shot, but this has resolved. He has already seen his PCP, lungs are clear, and Covid test was negative. He said that a week ago, he started to feel not quite right. He said that his lungs felt uber clean, but stated that he had a headache and nausea every now and then. He was wondering if it is related to the vaccination. He said that he went to the doctor and his O2 sat was 99% and she did not even think he needed a Covid test, but the rapid test was Covid negative. He stated that on the website that it says that up to 7 days after vaccination 77% of people reported fever, chills, headache and other symptoms. He said that he did not know that you could experience side effects a week after getting a vaccine. He said that his eases his mind a little bit. He wanted to know if it could be because of the vaccine? He stated that sometimes he feels fine and other times he feels strange. He stated that sometime he just feels different. He said that he received the vaccine on 24Dec2020. Caller said that sometimes he is perfectly fine and then he will get the headache or nausea for a few moments and then it would go away. Caller said that at the doctor's office his blood pressure was 118/78 and his O2 sat was 99% He stated that he does work around Covid patients and takes all precautions when he is around them. He said that exactly 12 hours later after receiving the vaccine at 2200 24Dec2020, he said that it felt like someone shot him in the arm. 2-3 hours after he got up on 25Dec2020 it was gone. Caller said that he rarely gets sick and has not had the flu vaccine. The outcome of the events nausea, and  headache was not recovered, and arm was sore was recovered on 25Dec2020, while unknown for the event feeling abnormal.
The documentation showed that we administered Covid 19  5-11 when in fact the patient was 13 years.
Redness, swelling and pain occurred in groin area on left side where 2 shots was given.  This occurred on 02/21/04, shots given 02/20/04.  Reported to MD on Sat 02/21, symptoms worsened by Sunday 02/22, area of swelling, redness, and pain got bigger and worsened.  This continued till 02/24, took her to hospital on 02/22 was told to give Motrin and Cold compresses until gone.  If it worsens, come back.  To whom it may concern: This was a scary thing fur us and my daughter.  By reporting this, I hope other parents will learn this can happen. But, I am also concerned with the future-will this reaction cause further problems?
It all started on the 16th of March in the evening, I had scratchy throat, nasal congestion and postnasal drip and a slight fever that night. The next night my fever spiked. I did take NYQUIL to help some of the issues. I reached out to the doctor and was given PAXLOVID, but I could take it. I tried to take the PAXLOVID, but it caused me to be vomited.
Headache, RespDepression, NauseaVomiting, Flushed skin, bilateral hand tingling Narrative:
PATIENT REPORTED FEELING NAUSEA 7/19/2011 ONE DAY AFTER BEING VACCINATED. AWOKE 07/20/2011 FEELING NAUSEATED WITH A HEADACHE, STATED SHE HAD NOT EATEN MUCH THE DAY PRIOR DUE TO NAUSEA. SHE THEN PASSED OUT WITHOUT WARNING AT 1 PM UPON ENTERING HER BATHROOM. SHE STATES SHE WAS UNCONSCIOUS X 5 MINUTES APPROXIMATELY. NO ONE ELSE WAS HOME.
Employee received Pfizer COVID19 vaccine dose 1. After 5 mins, complained of N/V , vertigo, chest tightness.
At clinic, patient experienced hives, pruritus, flushing, injection site redness, shortness of breath, sensation of throat closing, wheezing, tachycardia and diaphoresis. Epi given and patient transported to ED. Patient premedicated prior to her vaccination with prednisone 30 mg and Benadryl 25 mg. IV placed with IV fluids, steroids, H2 blocker, and antihistamines. Additionally, given her ongoing respiratory distress treated with epinephrine intramuscularly. Patient significantly improved after epinephrine and nebulizer.  No hypoxemia.  No hypotension.  Good aeration throughout all lung fields.  No significant wheezing.  Pruritus is resolved. Patient has improved significantly has been monitored for 4 hours without deterioration.  At this time, we will discharge the patient.
Patient came to pharmacy looking for his 2nd shingrix shot.  Administered vaccine and patient left.  Patient's primary MD called 10/14/20 to discuss the patient's vaccine history because her records indicated that was his 3rd dose.  Upon further investigation the patient received 4 total doses.  1st: 6/12/18, 2nd: 9/27/19, 3rd: 7/13/20, 4th: 10/12/20.  Patient has not called to report any adverse symptoms.
Receipt of seasonal influenza vaccine on 11/6/09. No other vaccines were received on that day. Within 40 minutes of vaccine receipt, service number (SM) developed an elevated temperature (measured, highest reading -103) and intense generalized body aches. His fevers continued for about 4 days and the myalgias lasted about 3 days. He denies associated rashes, angioedema, joint pain, headaches, N/V, dyspnea, or increased fatigue. SM did not seek medical evaluation, but self treated with Ibuprofen w/o significant improvement of symptoms. He denied  symptoms of infection or exposures to sick contacts prior to vaccine receipt. He denies previous adverse reactions following vaccine receipt.
three days of fever. Highest 102.2, vomiting, severe body aches, headache, swollen glands and multiple canker sores in my mouth.
PAIN AND WEAKNESS AT INJECTION SITE. HAND TINGLING . GENERAL PAIN AND DISCOMFORT
This case was reported by a physician via other manufacturer and described the occurrence of chills in a 21-year-old male patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced chills, pain, feeling unwell and fever. On an unknown date, the outcome of the chills, pain, feeling unwell and fever were unknown. It was unknown if the reporter considered the chills, pain, feeling unwell and fever to be related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. No additional patient information was provided. The reporter assumed that the reporter was also prescribing physician, but it was not certain. The reporter assumed that the vaccine was administered as protection against Pneumococcal Sero Group B. It was unknown whether any other medicines, medical conditions, or investigations were done. There was no medical information request. It was reported that, this case was previously reported to Food and Drug administration. The reporter had given consent to be contacted for further details.
Itching and hives; Itching and hives; Muscle aches; Arm soreness; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 41-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247) via an unspecified route of administration, in left arm on 29Apr2021 14:30 as single for COVID-19 immunisation. Medical history included of chronic autoimmune hives likely exacerbated by COVID vaccine, limited occurrence of hives since stopping oral contraceptive in Nov2020 and recent urinary tract infection (UTI). No allergies reported. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: L3247) via intramuscular route of administration, administered in arm left on 08Apr2021 at 12:30 (at the age of 41-year-old) as single dose for COVID-19 immunization. Concomitant medications included within 2 weeks of vaccination ascorbic acid, calcium phosphate, lactobacillus, vaccinium macrocarpon (AZO CRANBERRY), menotrophin (MENOPUR), follitropin beta (FOLLISTIM), nitrofurantoin and MVI (MULTIVITAMINS) all taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 29Apr2021, patient experienced arm soreness, fatigue and muscle aches on 30Apr2021. On 02May2021 01:00 the patient experienced itching and hives present on trunk, gluteal region, arms, legs, and scalp 3 days after second vaccine dose. The patient received treatment for the events was Zyrtec. The outcome of the events itching, and hives was not recovered and for all other events was unknown.  No follow-up attempts are needed. No further information is expected.